Quantcast

Latest Verenium Corporation Stories

2011-06-01 07:00:00

SAN DIEGO, June 1, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will host a live webcast of the Company's Analyst and Investor day on Tuesday, June 7, 2011 from The Four Seasons Hotel in New York City. The event will begin at 8:45 a.m. and is expected to conclude at 11:00 a.m. ET. A link to the live webcast may be accessed by...

2011-05-17 07:00:00

SAN DIEGO, May 17, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it received the CLARUS Award presented by MDB Capital Group at the second annual Bright Lights Conference in New York City on May 10th. The Bright Lights Conference is the only conference with an exclusive focus on publicly-traded companies possessing disruptive and market...

2011-05-12 15:00:00

SAN DIEGO, May 12, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported a summary of recent Company highlights and financial results for the first quarter ended March 31, 2011. "I am pleased with the operational and financial progress made in the first quarter," said James E. Levine, President and Chief Executive Officer at Verenium. "Product...

2011-05-11 07:00:00

SAN DIEGO, May 11, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced James Levine, President and Chief Executive Officer, will present at two upcoming conferences. Mr. Levine will present at the upcoming Barclays Capital Clean Solutions Conference as part of the "Biofuels" panel discussion scheduled from 1:30 - 3:00 p.m. ET on Thursday, May 19,...

2011-05-05 07:00:00

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release 2011 first quarter financial results on Thursday, May 12, 2011 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Thursday, May 12 at 5:00 p.m. ET. The call may be accessed by dialing 877-755-7422...

2011-05-03 07:05:00

SAN DIEGO, May 3, 2011 /PRNewswire/ -- Verenium Corporation (NASDAQ: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that Jeff Black, Senior Vice President and Chief Financial Officer, will present at the upcoming MDB Capital Group Bright Lights Conference. The presentation is scheduled to begin at 3:00 p.m. EDT on Tuesday, May 10, 2011 and will take place at the Le Parker Meridien Hotel in New York City. More...

2011-05-03 07:00:00

SAN DIEGO, May 3, 2011 /PRNewswire/ -- Verenium Corporation (NASDAQ: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that several members of management will speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing. The conference is taking place May 8-11, 2011 at the Toronto Convention Center. James Levine, President and Chief Executive Officer, will make opening remarks at a plenary...

2011-03-11 07:00:00

SAN DIEGO, March 11, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it repurchased $28.4 million in principal amount of its outstanding convertible notes in a series of privately-negotiated transactions. As part of these transactions, the Company repurchased $19.9 million in principal amount of its 5.5% Notes and $8.5 million in principal...

2011-03-01 15:01:00

SAN DIEGO, March 1, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today reported a summary of recent Company highlights and financial results for the fourth quarter and year ended December 31, 2010. "2010 was a year of significant progress for Verenium. Even as we completed the complex process of refocusing on our core enzymes business, we were able to achieve or exceed our...

2011-02-28 07:00:00

SAN DIEGO, Feb. 28, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of high-performance specialty enzymes, today announced that Terminal 6, a major producer of soybean meal, oil and biodiesel, has successfully begun use of Verenium's Purifine enzymatic degumming process at its Puerto General San Martin facility in Argentina. Purifine enzymatic degumming is a novel process that significantly increases yields in edible oil production and can have...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related